FDA inspection
Nexus Pharmaceuticals Inc: FDA inspection ending Jan 11, 2024
FDA inspection 1228840 · No Action Indicated (NAI) · Pleasant Prairie, WI
Key facts
| Inspection ID | 1228840 |
|---|---|
| Firm | Nexus Pharmaceuticals Inc |
| FEI number | 3017912110 |
| Address | 10300 128th Ave |
| City | Pleasant Prairie |
| State | WI |
| ZIP | 53158-7336 |
| Fiscal year | 2024 |
| Inspection end date | Jan 11, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data